ATN-161 (trifluoroacetate salt)產(chǎn)品描述:ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.IC50 & Target: Integrin α5β1[1]In Vitro: The combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to control and single-agent therapy (p<0.01). In addition, combination therapy leads to a significant increase of apoptotic (TUNEL-positive) tumor cells (p<0.03), wheras single-agent therapy does not increase in TUNEL-positive tumor cells. ATN-161 treatment leads to a significant reduction in EC number (21% decrease) after a 48 hr incubation time compared to control (p<0.03)[1]. ATN-161 inhibites VEGF-induced migration and capillary tube formation in hCECs, but did not inhibit proliferation. ATN-161 decreases the number of cells migrating in response to VEGF in a dose-dependent manner starting at 100 nM (P<0.001 vs. VEGF group)[2]. In Vivo:< 公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設(shè)有歐洲區(qū)子公司和亞洲區(qū)總代理,營銷網(wǎng)點遍及全球20多個國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領(lǐng)域的一流供應商, 產(chǎn)品涵蓋癌癥、神經(jīng)科學、抗感染、表觀遺傳學等20個熱門研究領(lǐng)域,PI3K、MAPK等近千個細分靶點,超過4000個活性小分子化合物現(xiàn)貨,以及GPCR、API、離子通道等超過20種不同類型的化合物庫,同時提供從毫克到千克的專業(yè)定制合成服務。 MCE 對每批產(chǎn)品都進行嚴格的LCMS和NMR檢驗,其產(chǎn)品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利; MCE 定期增加各領(lǐng)域熱門抑制劑、激動劑,不斷擴增已有化合物庫,以滿足最新的科研需求; 數(shù)千種產(chǎn)品在上海有充足備貨,24-48小時內(nèi)送達客戶; 大量產(chǎn)品提供免費試用裝;已為全球多個知名企業(yè)、院校構(gòu)建各種定制型化合物庫。 產(chǎn)品鏈接:www.medchemexpress.cn/atn-161-trifluoroacetate-salt.html |
ATN-161 (trifluoroacetate sal
發(fā)布日期:2017-11-06 瀏覽次數(shù):0
核心提示:a href=https://www.medchemexpress.com/ATN-161-trifluoroacetate-salt.htmlATN-161 (trifluoroacetate salt)/a產(chǎn)品描述:ATN-1
- 下一篇:暫無
- 上一篇:AZM475271研究進展
行業(yè)動態(tài)
更多...
- ATN-161 (trifluoroacetat 11-06
- AZM475271研究進展 11-06
- AVN-944研究進展 11-06
- Ascomycin研究進展 11-06
- β-Lapachone研究進展 11-06
- Anidulafungin研究進展 11-06
- Amsacrine (hydrochloride 11-06
- Amsacrine研究進展 11-06
- Uramustine研究進展 11-06
- Exherin (trifluoroacetat 11-06